We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Maintenance With Selinexor/Placebo After Combination Chemotherapy in Participants With Endometrial Cancer [SIENDO] (ENGOT-EN5)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03555422
Recruitment Status : Active, not recruiting
First Posted : June 13, 2018
Last Update Posted : October 10, 2022
Belgium and Luxembourg Gynaecological Oncology Group
North-Eastern German Society of Gynaecologic Oncology
Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies
Spanish Research Group in Ovarian Cancer
The Central and Eastern European Gynecologic Oncology Group
Israel Society of Gynecologic Oncology
The GOG Foundation, Inc.
Information provided by (Responsible Party):
Karyopharm Therapeutics Inc

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : March 2023
Estimated Study Completion Date : March 2023